Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of
associated complications has appreciably increased global expenditure in recent years. The …

Objective: The objective of this review was to examine the role of adverse drug events
(ADEs) caused by pharmacological interventions in cost-effectiveness models for diabetes …

Type 2 diabetes mellitus (T2DM) undermines health and quality of life (QoL). This cross-
sectional study surveyed 138 consenting T2DM patients from North-Eastern Romania with …

Objectives The incidence of type 1 diabetes mellitus is increasing every year requiring
substantial expenditure on treatment and complications. A systematic review was conducted …

Background. Diabetes mellitus rates and associated costs continue to rise across Europe
enhancing health authority focus on its management. The risk of complications is enhanced …

Background Cost-effectiveness analyses rarely offer useful insights to policy decisions
unless their results are compared against a benchmark threshold. The cost-effectiveness …

Methods This study was conducted using the French healthcare claims database (SNDS).
Adult patients living with type 1 or type 2 diabetes mellitus (T1DM or T2DM) initiating Gla …

Background: Diabetes is a health problem that has an enormous and intolerable public
health burden on the individual, family, and community. Diabetes affects nearly one-fifth of …

Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of
associated complications has appreciably increased global expenditure in recent years. The …

Tóm tắt Đặt vấn đề: Insulin degludec và insulin glargine là những loại insulin có tác dụng
chậm và kéo dài, giúp hạ đường huyết ổn định. Phân tích chi phí-hiệu quả liên quan đến …